Clinical Trial Update: Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 dose-escalation trial of 2-Deoxy-D-glucose (2DG) in adults with advanced solid tumors, spanning multiple cancer types and reported as complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• 2-Deoxy-D-glucose (2-Deoxy-D-glucose)

Snippet

Sponsor: Threshold Pharmaceuticals | Conditions: Lung Cancer, Breast Cancer | Phase 1 | Status: COMPLETED